XWELL (XWEL) to Announce Earnings on Monday

XWELL (NASDAQ:XWEL) is expected to announce its Q2 2026 results before the market opens on Monday, August 17th. Analysts expect the company to post earnings of ($1.00) per share and revenue of $2.3710 million for the quarter. Parties can check the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 20, 2026 at 5:00 PM ET.

XWELL (NASDAQ:XWEL) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($1.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51). XWELL had a negative net margin of 81.43% and a negative return on equity of 2,318.99%. The firm had revenue of $6.64 million for the quarter, compared to the consensus estimate of $2.37 million.

XWELL Stock Performance

XWELL stock opened at $1.02 on Monday. XWELL has a fifty-two week low of $0.26 and a fifty-two week high of $2.20. The stock has a market cap of $8.65 million, a PE ratio of -0.18 and a beta of 1.03. The firm’s 50-day simple moving average is $1.10 and its 200 day simple moving average is $1.06.

Analysts Set New Price Targets

XWEL has been the subject of several analyst reports. Wall Street Zen lowered shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. Weiss Ratings downgraded XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.